The Alcon Innovator Program aimed to gain patient insights from across the country to understand the most common areas of ...

Some say our eyes are a window to the soul and one tech company is taking that notion further with next-generation contact ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

It's by far the best value in VR. But the question is, should you upgrade to it or go with Meta's even better model?

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...